Apellis Pharmaceuticals, Inc. (APLS)

19.94 -0.59 (-2.87%) USD  |  NASDAQ  |  Jan 16, 16:00
20.05 +0.11 (+0.55%) After-Hours: 20:00
More

Apellis Pharmaceuticals EBITDA (TTM)

EBITDA (TTM) Chart

View EBITDA (TTM) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (TTM) Range, Past 5 Years

View EBITDA (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (TTM) Benchmarks

View EBITDA (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade